Gender Life Expectancy Gap Increased From 2010 to 2021
By Elana Gotkine HealthDay Reporter
MONDAY, Nov. 13, 2023 -- From 2010 to 2021, the gender life expectancy gap increased, with COVID-19 the leading contributor from 2019 to 2021, according to a research letter published online Nov. 13 in JAMA Internal Medicine.
Brandon W. Yan, M.D., M.P.H., from the University of California in San Francisco, and colleagues systematically examined the contribution of COVID-19 and other underlying causes of death to the widened gender life expectancy gap from 2010 to 2021 using mortality data from the National Center for Health Statistics.
The researchers found that the gender life expectancy gap increased 0.23 and 0.70 years from 2010 to 2019 and from 2019 to 2021, respectively. Prior to COVID-19 in 2020, for men versus women, the largest contributors to worsening life expectancy were unintentional injuries, diabetes, suicide, homicide, and heart disease (−0.23, −0.05, −0.04, −0.03, and −0.03 years [45.4, 10.1, 7.8, 5.3, and 4.9 percent], respectively). This was offset by differential improvement in mortality from cancer, Alzheimer disease, and chronic lower respiratory disease, among others, for men versus women (0.12, 0.06, and 0.04 years [43.1, 20.5, and 12.3 percent], respectively). COVID-19 became the leading contributor to the widening gender life expectancy gap from 2019 to 2021, followed by unintentional injuries (−0.33 and −0.27 years [39.8 and 32.5 percent], respectively). The increasing gap was partially mitigated by increasing maternal deaths among women and the relative reductions in cancer and perinatal conditions among men.
"This analysis finds that COVID-19 and the drug overdose epidemic were major contributors to the widening gender gap in life expectancy in recent years," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-11-14 07:13
Read more
- Clinical Practice Guidelines Updated for Primary Prevention of Stroke
- Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma
- Higher Heart Rate May Help Spur A-fib in Black Patients
- Mixed Link Seen for Gestational Exposure to Flame-Retardant Chemicals and Childhood Obesity
- Blood Test Might Spot Women in Labor at Risk for Preeclampsia
- Protracted Radiation Exposure Linked to Hematologic Cancer Mortality
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions